Upregulation of IGFBP2 expression was associated with angiogenic mimetic (VM) formation, leading to resistance to anti-VEGF therapy in glioma and had a significant immunosuppressive activity in GBM, which was negatively associated with patient survival (11). Here, IGFBP2 is linked to central nervous system cancer.